Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Submitted by
admin
on April 19, 2017 - 4:21pm
Source:
Fierce Pharma
News Tags:
earnings
drug pricing
Bristol-Myers Squibb
AbbVie
Roche
Headline:
Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Do Not Allow Advertisers to Use My Personal information
